Extracorporeal Affinity Therapy

Volume: 39 Number: 2 April 1, 2011
  • Adil Denizli
TR EN

Extracorporeal Affinity Therapy

Abstract

Extracorporeal therapies are directed at the removal of potential toxic substances including bilirubin, pathogenic antibodies, various circulating immune-complexes, cholesterol, toxic metal ions, etc. from human plasma. The conventional extracorporeal therapies including plasma exchange, hemodialysis, hemofiltration and hemoperfusion are non-selective techniques. In addition the requirement for plasma substitutes such as albumin is very high. Moreover, the dangers of hepatitis or immune reactions accompany these therapies while using plasma for plasma products. Today, one of the most promising procedures for extracorporeal therapy is specific affinity adsorption. Affinity carriers may be used in hemoperfusion system, where blood is directly perfused through the column filled with these carriers. This type of application is effective, simple and inexpensive. In this article, some interesting applications on extracorporeal affinity therapies for removal of toxic substances from human plasma are briefly reviewed.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Adil Denizli This is me

Publication Date

April 1, 2011

Submission Date

-

Acceptance Date

-

Published in Issue

Year 2011 Volume: 39 Number: 2

APA
Denizli, A. (2011). Extracorporeal Affinity Therapy. Hacettepe Journal of Biology and Chemistry, 39(2), 93-110. https://izlik.org/JA82MS43PX
AMA
1.Denizli A. Extracorporeal Affinity Therapy. HJBC. 2011;39(2):93-110. https://izlik.org/JA82MS43PX
Chicago
Denizli, Adil. 2011. “Extracorporeal Affinity Therapy”. Hacettepe Journal of Biology and Chemistry 39 (2): 93-110. https://izlik.org/JA82MS43PX.
EndNote
Denizli A (April 1, 2011) Extracorporeal Affinity Therapy. Hacettepe Journal of Biology and Chemistry 39 2 93–110.
IEEE
[1]A. Denizli, “Extracorporeal Affinity Therapy”, HJBC, vol. 39, no. 2, pp. 93–110, Apr. 2011, [Online]. Available: https://izlik.org/JA82MS43PX
ISNAD
Denizli, Adil. “Extracorporeal Affinity Therapy”. Hacettepe Journal of Biology and Chemistry 39/2 (April 1, 2011): 93-110. https://izlik.org/JA82MS43PX.
JAMA
1.Denizli A. Extracorporeal Affinity Therapy. HJBC. 2011;39:93–110.
MLA
Denizli, Adil. “Extracorporeal Affinity Therapy”. Hacettepe Journal of Biology and Chemistry, vol. 39, no. 2, Apr. 2011, pp. 93-110, https://izlik.org/JA82MS43PX.
Vancouver
1.Adil Denizli. Extracorporeal Affinity Therapy. HJBC [Internet]. 2011 Apr. 1;39(2):93-110. Available from: https://izlik.org/JA82MS43PX

HACETTEPE JOURNAL OF BIOLOGY AND CHEMİSTRY

Copyright © Hacettepe University Faculty of Science

http://www.hjbc.hacettepe.edu.tr/

https://dergipark.org.tr/tr/pub/hjbc